FDA Approved: RADICAVA — Original Application (Shionogi Inc.)

View source ↗

Summary

FDA approved the original application for RADICAVA (edaravone) by Shionogi Inc. for the treatment of amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Radicava (edaravone)

Snippet

ORIG AP for RADICAVA (EDARAVONE)